One patient: C’mon, doc, EHRs aren’t all bad

Cara Livernois | | Health Exec | EMR/EHR

Stories about the horrors of electronic health records (EHRs) are aplenty—with three physicians writing letters to the Wall Street Journal.

But one response emphasizes the patient's point of view, which can paint EHRs in a much better light. Fred Butzen wrote to the WSJ about he felt going for a routine checkup to a physician with a well-implemented EHR system. He was able to witness his physician order ultrasounds and blood tests, and then see the results through images and discuss results with his doctor.

“He spent his time talking with and listening to me. The time we spent together was productive,” wrote Butzen.

Read the full letter by clicking the link below:

If Used Properly, EMRs Can Help Patients

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.